Back
Takeda Pharmaceutical Co., Ltd. 10K Form
Sell
43
TKPHF
Takeda Pharmaceutical Co., Ltd.
Last Price:
$28.61
Seasonality Move:
6.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TKPHF News And Ratings
See the #1 stock for the next 7 days that we like better than TKPHF
TKPHF Financial Statistics
Sales & Book Value
| Annual Sales: | $30.1B |
|---|---|
| Cash Flow: | $2B |
| Price / Cash Flow: | 8.42 |
| Annual Sales: | $30.57 |
| Price / Book: | 0.94 |
Profitability
| EPS (TTM): | 0.15760 |
|---|---|
| Net Income (TTM): | $260.5M |
| Gross Margin: | $16.1B |
| Return on Equity: | 0.55% |
| Return on Assets: | 0.27% |
Takeda Pharmaceutical Co., Ltd. Earnings Forecast
Key Takeda Pharmaceutical Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 26 years for TKPHF is 53.59%.
-
The Selling, General & Administrative Expenses for TKPHF have been equal to 24.11% of Gross Profit Margin.
-
The Research & Development expenses have been 15.94% of Revenue.
-
The Interest Expense is 172.90% of Operating Income.
-
The Net Earning history of TKPHF is 2.36% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Takeda Pharmaceutical Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TKPHF |
| Website: | takeda.com |
Debt
| Debt-to-Equity Ratio: | 0.65 |
|---|---|
| Current Ratio: | 1.37 |
| Quick Ratio: | 0.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 64.87 |
|---|---|
| Forward P/E Ratio: | 0 |
TKPHF Technical Analysis vs Fundamental Analysis
Sell
43
Takeda Pharmaceutical Co., Ltd. (TKPHF)
is a Sell
Is Takeda Pharmaceutical Co., Ltd. a Buy or a Sell?
-
Takeda Pharmaceutical Co., Ltd. stock is rated a SellThe current Takeda Pharmaceutical Co., Ltd. [TKPHF] share price is $28.61. The Score for TKPHF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.